Effects of corilagin on alleviating cholestasis via farnesoid X receptor‐associated pathways in vitro and in vivo
Authors:
Open Access
- 12 December 2017
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 175 (5) , 810-829
Abstract
Background and Purpose: The aim of this study was to investigate the ameliorative effects of corilagin on intrahepatic cholestasis induced by regulating liver farnesoid X receptor (FXR)‐associated pathways in vitro and in vivo.Experimental Approach: Cellular and animal models were treated with different concentrations of corilagin. In the cellular experiments, FXR expression was up‐regulated by either lentiviral transduction or GW4064 treatment and down‐regulated by either siRNA technology or treatment with guggulsterones. Real‐time PCR and Western blotting were employed to detect the mRNA and protein levels of FXR, SHP1, SHP2, UGT2B4, BSEP, CYP7A1, CYP7B1, NTCP, MRP2 and SULT2A1. Immunohistochemistry was used to examine the expression of BSEP in liver tissues. Rat liver function and pathological changes in hepatic tissue were assessed using biochemical tests and haematoxylin and eosin staining.Results: Corilagin increased the mRNA and protein levels of FXR, SHP1, SHP2, UGT2B4, BSEP, MRP2 and SULT2A1, and decreased those of CYP7A1, CYP7B1 and NTCP. After either up‐ or down‐regulating FXR using different methods, corilagin could still increase the mRNA and protein levels of FXR, SHP1, SHP2, UGT2B4, BSEP, MRP2 and SULT2A1 and decrease the protein levels of CYP7A1, CYP7B1 and NTCP, especially when administered at a high concentration. Corilagin also exerted a notable effect on the pathological manifestations of intrahepatic cholestasis, BSEP staining in liver tissues and liver function.Conclusions and Implications: Corilagin exerts a protective effect in hepatocytes and can prevent the deleterious activities of intrahepatic cholestasis by stimulating FXR‐associated pathways.Keywords
Funding Information
- Huazhong University of Science and Technology (2017KFYXJJ238)
- National Natural Science Foundation of China (81371840, 81600373)
This publication has 61 references indexed in Scilit:
- Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasisBMC Gastroenterology, 2013
- A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathwaysBMC Complementary and Alternative Medicine, 2013
- Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasisJournal of Clinical Investigation, 2011
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Nuclear receptors as therapeutic targets in cholestatic liver diseasesBritish Journal of Pharmacology, 2008
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver RegenerationScience, 2006
- Antihypertensive effect of corilagin in the ratCanadian Journal of Physiology and Pharmacology, 1995